Celebrating the Breakthroughs Shaping the Future of Canine Health. Meet the 2025 Canine Health Discovery Award Finalists.

Knowledge Hub

Access valuable information to help pet owners and veterinarians improve canine health and quality of life.

Skin & Allergies Research

The AKC Canine Health Foundation (CHF) funds research aimed at improving the health of dogs by understanding, diagnosing, and treating skin and allergic diseases.

Read More

Lipid Profiles to Diagnose Atopy

Atopic dermatitis, or atopy, is the most common inflammatory skin disease in people and dogs. It is caused by an abnormal immune response to environmental allergens that penetrate the skin’s outer protective layer. Clinical signs include itching, scratching, and licking which predispose the skin to secondary infection. There is no definitive diagnostic test for atopy […]

Read More

02694: Investigation on the Molecular Crosstalk between Canine Atopic Skin and Microbes: Unraveling Potential Pathomechanisms for Chronic Recurrent Skin Infections

Environmental allergy is extremely common in dogs. Alterations of the skin barrier may lead to an altered inflammatory signal in allergic skin cells that perpetuates the inflammatory response and alters the interaction between skin cells and the external environment. Microorganisms have been shown to be more adherent on allergic compared with healthy skin. This increased […]

Read More

03166-A: Evaluation of the Effects of Diluted Sodium Hypochlorite on Skin Microbiome in Dogs with Superficial Pyoderma and Atopic Dermatitis: a Single Blinded, Randomized, Controlled Clinical Trial

In canine allergies, recurrent skin infection is frequent, often requiring repeated antibiotic use. This leads to a financial burden on owners and higher risk for antibiotic resistance. Recent studies in people have shown that diluted bleach baths can help patients with allergies and skin infections. In dogs, bleach has shown antimicrobial and anti-inflammatory effects in […]

Read More

The Low Down on the Wipe Down for Working Dogs

Introduction Search and rescue dogs and military working dogs provide valuable services to help keep us safe, but they are often deployed to areas contaminated with hazardous materials such as petroleum products, heavy metals, and volatile organic solvents. Regular decontamination of the dogs’ fur and skin is recommended, but there is little objective data on […]

Read More

00680-A: Screening of Healthy Dogs and Dogs with Chronic Allergic Dermatitis for Colonization of the Skin by Methicillin-Resistant Strains of Staphylococci

Bacterial skin infection (pyoderma) is the most common skin disease occurring in dogs. Greater than 90 percent of pyoderma in dogs is caused by Staphylococcus spp. bacteria, and canine skin is more susceptible to staphylococcal infections than the skin of human beings or any other domestic species. In dogs with allergic skin diseases (which may […]

Read More

02182-A: Is Defective Secretion of Antimicrobial Peptides Associated with Reduced Microbicidal Effects in Atopic Keratinocytes?

Antimicrobial peptides (AMPs) are small proteins produced by many organisms. They have multiple functions, the most important of which is the defense against pathogens. The antimicrobial activity of such proteins has been demonstrated against multiple microorganisms. Recently, a lack of secretion of AMPs, after exposure to bacteria in human skin cells harvested from allergic patients, […]

Read More

02837: Duration of Antibiotic Therapy for Canine Superficial Pyoderma: Is the One-Week Post Resolution of Clinical Signs a Valid Rule-of-Thumb?

Canine superficial bacterial skin infection in dogs is the main presentation leading to antibiotic use in small animal practice. Commonly prescribed duration of treatment for bacterial infections are not evidence-based and it has been anecdotally recommended that all cases of bacterial skin infections take antibiotics for seven days beyond clinical resolution of lesions. Bacterial skin […]

Read More

Exploring Biomarkers for Atopic Dermatitis

Atopic dermatitis in dogs, also known as atopy or seasonal allergies, is a common and frustrating problem affecting up to 25% of dogs in the United States. The disease is characterized by an exaggerated immune system response to allergens in the environment. Intense itching is the most common clinical sign, accompanied by secondary skin and […]

Read More

03433: Identification of commensal skin bacteria that inhibit the growth of methicillin resistant Staphylococcus pseudintermedius and their associated bacteriocins

Lay Abstract: Staphylococcus pseudintermedius is one of the most common causes of infection in dogs. However, these infections are typically endogenous stemming from the dog’s own skin microbiome. Despite this, antimicrobial resistance (AMR) in this pathogen is booming. Our clinical laboratory has observed multi-drug resistance (MDR) in 75.7% of S. pseudintermedius isolates. In fact, pan-resistant […]

Read More

02111-A: Evaluating the Contribution of Fungal Infection to the Pathogenesis of Atopic Dermatitis: Putting Evidence under the Use of Antifungal Medication

This study utilized next-generation sequencing to describe the natural fungal microbiome (mycobiome) of canine skin and to identify changes in the mycobiome when allergic skin disease is present. Superficial skin swabs from ten dogs with healthy skin and eight dogs with allergic skin disease were collected from haired and non-haired sites, 10 sites for healthy […]

Read More

02921-MOU: Transcriptome Profiling of Canine Familial Dermatomyositis Skin Lesions and Treatment with a JAK Inhibitor to Identify Novel Pathways Involved in Pathogenesis

Dermatomyositis (DMS) is a chronic inflammatory and autoimmune disorder affecting primarily skin and muscle in both humans and dogs. Familial canine DMS is mainly described in predisposed breeds, such as Collies and Shetland Sheepdogs, and is characterized by severe inflammatory lesions leading to skin scarring with disfiguration, increased morbidity and decreased quality of life. Full […]

Read More

02176-A: Intralymphatic Immunotherapy for the Treatment of Canine Atopic Dermatitis

Atopic dermatitis (AD) is a genetically predisposed inflammatory skin condition affecting approximately 10% of dogs globally and is probably the most prevalent skin disease in all canines. Affected dogs manifest with itchy skin and ears and secondary infections. Clinical features are associated with IgE antibodies produced against indoor/outdoor environmental allergens. Breeds such as Boxers, Terriers, […]

Read More

03162: Fecal Microbiota Transplantation for Treatment of Canine Atopic Dermatitis

Atopic dermatitis is a common inflammatory and itchy skin disease, constituting a global issue that affects millions of people and dogs world-wide. The pathogenesis of this disease is known to be multifactorial and not only consisting of skin barrier dysfunction, but also with immunological dysregulation and skin microbiota changes playing a central role.In humans, establishment […]

Read More

02116-A: Establishing Best Practices in the Treatment of Atopic Dermatitis to Prevent Antimicrobial Resistance

Atopic dermatitis (AD/Allergic skin disease) is a common condition affecting approximately 10% of the canine population, with strong breed predilections. Affected dogs often succumb to recurrent bacterial skin infections, namely by Staphylococcus species. As in human medicine, one of the major obstacles in treating these infections is combating antimicrobial resistance. Frequently, multidrug resistant (MDR) bacteria […]

Read More

01240-A: Development of a Diagnostic Method for Canine Atopic Dermatitis

Grant Status: Closed Grant Amount: $11,880 Daniel A. Gingerich, DVM; Imulan Bio Therapeutics, LLC May 1, 2009 – April 30, 2010 Sponsor(s): American Cavalier King Charles Spaniel Club Charitable Trust, American Sealyham Terrier Club, Boston Terrier Club of America Charitable Trust, Chinook Health Fund, French Bulldog Club of America, Sally Z. Monroe, MD FUND, Samoyed […]

Read More